Wave Life Sciences Ownership | Who Owns Wave Life Sciences?
Wave Life Sciences Ownership Summary
Wave Life Sciences is owned by 84.67% institutional investors, 15.93% insiders. Ra capital management is the largest institutional shareholder, holding 11.10% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.68% of its assets in Wave Life Sciences shares.
WVE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Wave Life Sciences | 84.67% | 15.93% | -0.60% |
Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 18.20M | 11.10% | $118.31M |
Adage capital partners gp | 15.02M | 9.16% | $97.61M |
Blackrock funding, inc. /de | 10.38M | 6.33% | $67.49M |
Blackrock | 6.74M | 5.21% | $33.63M |
Maverick capital | 8.26M | 5.04% | $53.70M |
Driehaus capital management | 6.53M | 3.98% | $42.45M |
Price t rowe associates inc /md/ | 5.10M | 3.88% | $63.07M |
Artal group | 4.57M | 3.53% | $22.79M |
M28 capital management lp | 5.66M | 3.45% | $36.82M |
Kynam capital management, lp | 4.56M | 2.78% | $29.64M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
M28 capital management lp | 5.66M | 62.80% | $36.82M |
Kynam capital management, lp | 4.56M | 3.19% | $29.64M |
Pfizer | 1.88M | 2.12% | $12.19M |
Ra capital management | 18.20M | 1.99% | $118.31M |
Stempoint capital lp | 900.34K | 1.88% | $5.85M |
Affinity asset advisors | 2.00M | 1.78% | $13.00M |
683 capital management | 4.10M | 1.75% | $26.65M |
Bioimpact capital | 1.51M | 1.70% | $9.78M |
Siren | 3.70M | 1.24% | $24.03M |
Maverick capital | 8.26M | 0.81% | $53.70M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adage capital partners gp | 15.02M | 0.16% | 2.50M |
Price t rowe associates inc /md/ | 5.10M | 0.01% | 1.97M |
Loomis sayles & co l p | 3.30M | 0.03% | 859.16K |
Stempoint capital lp | 900.34K | 1.88% | 810.50K |
Blackrock funding, inc. /de | 10.38M | 0.00% | 755.10K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Takeda pharmaceutical | - | - | -1.35M |
Silverarc capital management | - | - | -1.05M |
Laurion capital management lp | - | - | -516.47K |
Exome asset management | - | - | -488.13K |
Avidity partners management lp | - | - | -350.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Ensign peak advisors | 313.31K | 0.00% | 313.31K | $2.04M |
Ikarian capital | 161.14K | 0.20% | 161.14K | $1.05M |
Sofinnova investments | 117.90K | 0.05% | 117.90K | $766.37K |
Compass rose asset management, lp | 100.00K | 0.13% | 100.00K | $650.00K |
Norges bank | 100.00K | 0.00% | 100.00K | $1.24M |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Nelson, van denburg & campbell wealth management group | -12.00 |
Capital performance advisors llp | -13.00 |
Corecap advisors | -24.00 |
Stephens consulting | -40.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 181 | -11.27% | 138,844,683 | 5.73% | 84 | 1.30% | 106 | -9.40% | 41 | -21.15% |
Mar 31, 2025 | 202 | 6.88% | 131,254,882 | 2.11% | 80 | 0.84% | 116 | -3.33% | 51 | 34.21% |
Dec 31, 2024 | 81 | -50.61% | 32,943,703 | -72.58% | 25 | 0.31% | 57 | -40.00% | 14 | -64.10% |
Sep 30, 2024 | 163 | 10.88% | 118,791,972 | 26.74% | 89 | 1.71% | 95 | 15.85% | 39 | -15.22% |
Jun 30, 2024 | 147 | 9.70% | 93,731,224 | 2.54% | 72 | 1.45% | 82 | -6.82% | 46 | 43.75% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 4.09M | 2.68% | - |
iShares Russell 2000 ETF | 2.64M | 1.66% | -50.19K |
PRIMECAP Odyssey Aggressive Growth | 2.39M | 1.50% | -46.94K |
US Small-Cap Growth II Equity Comp | 2.13M | 1.37% | 513.86K |
T. Rowe Price New Horizons | 2.13M | 1.37% | 323.96K |
Loomis Sayles Small Cap Growth Instl | 1.85M | 1.16% | -32.63K |
Artisan International Small-Mid Investor | 1.51M | 0.97% | -102.46K |
Artisan Non-U.S. Small-Mid Growth Comp | 1.51M | 0.97% | -102.46K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.28M | 0.81% | -575.53K |
T. Rowe Price Health Sciences | 1.07M | 0.69% | 172.73K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 15, 2025 | Tan Aik Na | - | Sell | $194.25K |
Aug 13, 2025 | HENRY CHRISTIAN O | - | Sell | $85.19K |
Aug 05, 2025 | TAKANASHI KEN | - | Sell | $42.63K |
Aug 05, 2025 | Tan Aik Na | - | Sell | $9.86K |
Jun 13, 2025 | Verdine Gregory L. | - | Sell | $208.50K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 3 |
2025 Q2 | - | 1 |
2025 Q1 | - | 2 |
2024 Q4 | - | 8 |
2024 Q3 | 1 | 2 |
WVE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools